UTMD Utah Medical Products, Inc.
Healthcare$65.22+1.10%ClosedMarket Cap: $207.7M
As of 2026-05-26
Valuation
P/E (TTM)
18.02
PEG
—
P/B
1.71
P/S
5.47
EV/EBITDA
7.85
DCF Value
$94.27
FCF Yield
6.3%
Div Yield
1.9%
Margins & Returns
Gross Margin
53.6%
Operating Margin
28.8%
Net Margin
28.9%
ROE
9.1%
ROA
8.7%
ROIC
7.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.7M | 60.6% | $2.6M | $2.6M | $— | $0.31 |
| Q4 null | $9.0M | 52.3% | $2.4M | $2.6M | $— | $0.31 |
| FY null | $38.5M | 51.6% | $11.4M | $11.3M | $— | $1.22 |
| Q3 null | $9.8M | 51.6% | $2.6M | $2.6M | $— | $0.31 |
| Q2 null | $10.0M | 50.8% | $3.2M | $3.0M | $— | $0.31 |
| Q1 null | $9.7M | 57.0% | $3.2M | $3.0M | $— | $0.31 |
| Q4 null | $9.2M | 58.1% | $2.9M | $2.9M | $— | $0.31 |
| FY null | $40.9M | 59.0% | $13.6M | $13.9M | $— | $1.21 |
| Q3 null | $10.0M | 52.7% | $3.3M | $3.6M | $— | $0.30 |
| Q2 null | $10.4M | 55.2% | $3.4M | $3.5M | $— | $0.30 |
| Q1 null | $11.3M | 59.7% | $3.9M | $4.0M | $— | $0.30 |
| Q4 2023 | $12.3M | 57.6% | $3.9M | $4.3M | $1.18 | $0.30 |